Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes

Stem Cell Research and Therapy

Volumn 5, Issue 1, 2014, Pages

  Keung, Wendy ^a,b   Boheler, Kenneth R ^a,b,c   Li, Ronald A ^a,b,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALSEQUESTRIN; MICRORNA; PHOSPHOLAMBAN; RYANODINE RECEPTOR; THYROID HORMONE;

ADRENERGIC SYSTEM; AEROBIC METABOLISM; CALCIUM BINDING; CALCIUM CURRENT; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL ENERGY; CELL MATURATION; CELL METABOLISM; EMBRYONIC STEM CELL; GLYCOLYSIS; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HISTONE MODIFICATION; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM; STEM CELL CULTURE; TRANSCRIPTOMICS; ACTION POTENTIAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOLOGY; ENERGY METABOLISM; METABOLISM; PARACRINE SIGNALING; PHYSIOLOGY;

ACTION POTENTIALS; CALCIUM SIGNALING; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENERGY METABOLISM; HUMANS; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; PLURIPOTENT STEM CELLS;

EID: 84893395943     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt406     Document Type: Review

References (99)

1. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. C Mummery, D Ward-van Oostwaard, P Doevendans, R Spijker, S van den Brink, R Hassink, M van der Heyden, T Opthof, M Pera, AB de la Riviere, R Passier, L Tertoolen, Circulation 2003 107 2733 2740 10.1161/01.CIR.0000068356.38592.68 12742992 (Pubitemid 36667249)
2. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. I Kehat, D Kenyagin-Karsenti, M Snir, H Segev, M Amit, A Gepstein, E Livne, O Binah, J Itskovitz-Eldor, L Gepstein, J Clin Invest 2001 108 407 414 11489934 (Pubitemid 32730787)
3. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. XQ Xu, R Graichen, SY Soo, T Balakrishnan, SN Rahmat, S Sieh, SC Tham, C Freund, J Moore, C Mummery, A Colman, R Zweigerdt, BP Davidson, Differentiation 2008 76 958 970 18557764
4. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. N Cao, Z Liu, Z Chen, J Wang, T Chen, X Zhao, Y Ma, L Qin, J Kang, B Wei, L Wang, Y Jin, HT Yang, Cell Res 2012 22 219 236 10.1038/cr.2011.195 22143566
5. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. TC McDevitt, MA Laflamme, CE Murry, J Mol Cell Cardiol 2005 39 865 873 10.1016/j.yjmcc.2005.09. 007 16242146 (Pubitemid 41572319)
6. Human cardiovascular progenitor cells develop from a KDR+embryonic-stem- cell-derived population. L Yang, MH Soonpaa, ED Adler, TK Roepke, SJ Kattman, M Kennedy, E Henckaerts, K Bonham, GW Abbott, RM Linden, LJ Field, GM Keller, Nature 2008 453 524 528 10.1038/nature06894 18432194 (Pubitemid 351733312)
7. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. Y Ren, MY Lee, S Schliffke, J Paavola, PJ Amos, X Ge, M Ye, S Zhu, G Senyei, L Lum, BE Ehrlich, Y Qyang, J Mol Cell Cardiol 51 280 287 10.1016/j.yjmcc.2011.04.012
8. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. DA Elliott, SR Braam, K Koutsis, ES Ng, R Jenny, EL Lagerqvist, C Biben, T Hatzistavrou, CE Hirst, QC Yu, RJ Skelton, D Ward-van Oostwaard, SM Lim, O Khammy, X Li, SM Hawes, RP Davis, AL Goulburn, R Passier, OW Prall, JM Haynes, CW Pouton, DM Kaye, CL Mummery, AG Elefanty, EG Stanley, Nat Methods 8 1037 1040 10.1038/nmeth.1740
9. Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. I Karakikes, GD Senyei, J Hansen, CW Kong, EU Azeloglu, F Stillitano, DK Lieu, J Wang, L Ren, JS Hulot, R Iyengar, RA Li, RJ Hajjar, Stem Cells Transl Med 2013 [epub ahead of print]
10. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. MA Laflamme, KY Chen, AV Naumova, V Muskheli, JA Fugate, SK Dupras, H Reinecke, C Xu, M Hassanipour, S Police, C O'Sullivan, L Collins, Y Chen, E Minami, EA Gill, S Ueno, C Yuan, J Gold, CE Murry, Nat Biotechnol 2007 25 1015 1024 10.1038/nbt1327 17721512 (Pubitemid 47517637)
11. Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. SL Paige, T Osugi, OK Afanasiev, L Pabon, H Reinecke, CE Murry, PLoS One 2012 5 11134
12. A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors. JE Hudson, RJ Mills, JE Frith, G Brooke, P Jaramillo-Ferrada, EJ Wolvetang, JJ Cooper-White, Stem Cells Dev 2011 20 77 87 10.1089/scd.2009.0497 20446813
13. A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells. ZH Weng, I Karakikes, CW Kong, H Ren, JZ He, L Geng, MZ Chow, W Keung, RJ Hajjar, RA Li, CW Chan, Stem Cells Dev 2013 in press
14. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. M Snir, I Kehat, A Gepstein, R Coleman, J Itskovitz-Eldor, E Livne, L Gepstein, Am J Physiol Heart Circ Physiol 2003 285 2355 H2363 14613910
15. Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. C Robertson, DD Tran, SC George, Stem Cells 2013 31 829 837 10.1002/stem.1331 23355363
16. Absence of transverse tubules contributes to non-uniform Ca(2+) wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. DK Lieu, J Liu, CW Siu, GP McNerney, HF Tse, A Abu-Khalil, T Huser, RA Li, Stem Cells Dev 2009 18 1493 1500 10.1089/scd.2009.0052 19290776
17. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. SD Lundy, WZ Zhu, M Regnier, MA Laflamme, Stem Cells Dev 2013 22 1991 2002 10.1089/scd.2012.0490 23461462
18. Functional cardiomyocytes derived from human induced pluripotent stem cells. J Zhang, GF Wilson, AG Soerens, CH Koonce, J Yu, SP Palecek, JA Thomson, TJ Kamp, Circ Res 2009 104 30 e41 10.1161/CIRCRESAHA.108.192237 19213953
19. Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. JC Moore, J Fu, YC Chan, D Lin, H Tran, HF Tse, RA Li, Biochem Biophys Res Commun 2008 372 553 558 10.1016/j.bbrc.2008.05.076 18503758
20. Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. E Poon, CW Kong, RA Li, Mol Pharmaceut 2011 8 1495 1504 10.1021/mp2002363
21. The effect of human and mouse fibroblast feeder cells on cardiac differentiation of human pluripotent stem cells. M Pekkanen-Mattila, M Ojala, E Kerkela, K Rajala, H Skottman, K Aalto-Setala, Stem Cells Int 2012 2012 875059 22315618
22. Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. C Kim, M Majdi, P Xia, KA Wei, M Talantova, S Spiering, B Nelson, M Mercola, HS Chen, Stem Cells Dev 2010 19 783 795 10.1089/scd.2009.0349 20001453
23. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Q Zhang, J Jiang, P Han, Q Yuan, J Zhang, X Zhang, Y Xu, H Cao, Q Meng, L Chen, T Tian, X Wang, P Li, J Hescheler, G Ji, Y Ma, Cell Res 2011 21 579 587 10.1038/cr.2010.163 21102549
24. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. J Ma, L Guo, SJ Fiene, BD Anson, JA Thomson, TJ Kamp, KL Kolaja, BJ Swanson, CT January, Am J Physiol Heart Circ Physiol 2011 301 2006 H2017 10.1152/ajpheart.00694.2011 21890694
25. Amiodarone reduces transmural heterogeneity of repolarization in the human heart. E Drouin, G Lande, F Charpentier, J Am College Cardiol 1998 32 1063 1067 10.1016/S0735-1097(98)00330-1 (Pubitemid 28459600)
26. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype. M Pekkanen-Mattila, H Chapman, E Kerkela, R Suuronen, H Skottman, AP Koivisto, K Aalto-Setala, Exp Biol Med 2010 235 522 530 10.1258/ebm.2010.009345
27. beta(1)- and beta(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. M Brito-Martins, SE Harding, NN Ali, Br J Pharmacol 2008 153 751 759 10.1038/sj.bjp.0707619 18193079 (Pubitemid 351271760)
28. Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy. F Pillekamp, M Haustein, M Khalil, M Emmelheinz, R Nazzal, R Adelmann, F Nguemo, O Rubenchyk, K Pfannkuche, M Matzkies, M Reppel, W Bloch, K Brockmeier, J Hescheler, Stem Cells Dev 21 2111 2121 10.1089/scd.2011.0312
29. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. IC Turnbull, I Karakikes, GW Serrao, P Backeris, JJ Lee, C Xie, G Senyei, RE Gordon, RA Li, FG Akar, RJ Hajjar, JS Hulot, KD Costa, FASEB J 2013 [Epub ahead of print]
30. Cardiac excitation-contraction coupling. DM Bers, Nature 2002 415 198 205 10.1038/415198a 11805843 (Pubitemid 34059525)
31. Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction. K Dolnikov, M Shilkrut, N Zeevi-Levin, S Gerecht-Nir, M Amit, A Danon, J Itskovitz-Eldor, O Binah, Stem Cells 2006 24 236 245 10.1634/stemcells.2005-0036 16322641 (Pubitemid 44464791)
32. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. J Liu, JD Fu, CW Siu, RA Li, Stem Cells 2007 25 3038 3044 10.1634/stemcells.2007-0549 17872499 (Pubitemid 350294429)
33. Mechanistic basis of excitation-contraction coupling in human pluripotent stem cell-derived ventricular cardiomyocytes revealed by Ca spark characteristics: direct evidence of functional Ca2 + -induced Ca2+ release. S Li, H Cheng, GF Tomaselli, RA Li, Heart Rhythm 2013
34. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models. CW Kong, FG Akar, RA Li, Thromb Haemost 2010 104 30 38 10.1160/TH10-03-0189 20539906
35. Na+/Ca2+ exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes. JD Fu, P Jiang, S Rushing, J Liu, N Chiamvimonvat, RA Li, Stem Cells Dev 2010 19 773 782 10.1089/scd.2009.0184 19719399
36. Facilitated maturation of Ca2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. J Liu, DK Lieu, CW Siu, JD Fu, HF Tse, RA Li, Am J Physiol Cell Physiol 2009 297 152 159 10.1152/ajpcell.00060.2009 19357236
37. Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. I Germanguz, O Sedan, N Zeevi-Levin, R Shtrichman, E Barak, A Ziskind, S Eliyahu, G Meiry, M Amit, J Itskovitz-Eldor, O Binah, J Cell Mol Med 2011 15 38 51 10.1111/j.1582-4934.2009. 00996.x 20041972
38. Embryonic stem cells in predictive cardiotoxicity: laser capture microscopy enables assay development. KW Chaudhary, NX Barrezueta, MB Bauchmann, AJ Milici, G Beckius, DB Stedman, JE Hambor, WL Blake, JD McNeish, A Bahinski, GG Cezar, Toxicol Sci 2006 90 149 158 16357009 (Pubitemid 43264735)
39. Quantitative study on the relation between structural and functional properties of the hearts from three different mammals. HD Kim, CH Kim, BJ Rah, HI Chung, TS Shim, Anat Rec 1994 238 199 206 10.1002/ar.1092380206 8154606 (Pubitemid 24018183)
40. Mitochondrial dynamics in the adult cardiomyocytes: which roles for a highly specialized cell? J Piquereau, F Caffin, M Novotova, C Lemaire, V Veksler, A Garnier, R Ventura-Clapier, F Joubert, Front Physiol 2013 4 102 23675354
41. Postnatal development of mouse heart: formation of energetic microdomains. J Piquereau, M Novotova, D Fortin, A Garnier, R Ventura-Clapier, V Veksler, F Joubert, J Physiol 2010 588 2443 2454 10.1113/jphysiol.2010.189670 20478976
42. Physical coupling supports the local Ca2+ transfer between sarcoplasmic reticulum subdomains and the mitochondria in heart muscle. C Garcia-Perez, G Hajnoczky, G Csordas, J Biol Chem 2008 283 32771 32780 10.1074/jbc.M803385200 18790739
43. Nongenetic method for purifying stem cell-derived cardiomyocytes. F Hattori, H Chen, H Yamashita, S Tohyama, YS Satoh, S Yuasa, W Li, H Yamakawa, T Tanaka, T Onitsuka, K Shimoji, Y Ohno, T Egashira, R Kaneda, M Murata, K Hidaka, T Morisaki, E Sasaki, T Suzuki, M Sano, S Makino, S Oikawa, K Fukuda, Nat Methods 2010 7 61 66 10.1038/nmeth.1403 19946277
44. The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells. JC St John, J Ramalho-Santos, HL Gray, P Petrosko, VY Rawe, CS Navara, CR Simerly, GP Schatten, Cloning Stem Cells 2005 7 141 153 10.1089/clo.2005.7.141 16176124 (Pubitemid 43150270)
45. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. S Chung, PP Dzeja, RS Faustino, C Perez-Terzic, A Behfar, A Terzic, Nat Clin Pract Cardiovasc Med 2007 4 60 S67 17230217
46. Control of mitochondrial ATP synthesis in the heart. DA Harris, AM Das, Biochem J 1991 280 561 573 1837214
47. Developmental changes in energy substrate use by the heart. GD Lopaschuk, RL Collins-Nakai, T Itoi, Cardiovasc Res 1992 26 1172 1180 10.1093/cvr/26.12. 1172 1288863 (Pubitemid 23010529)
48. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. P Rana, B Anson, S Engle, Y Will, Toxicol Sci 2012 130 117 131 10.1093/toxsci/kfs233 22843568
49. Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. GD Lopaschuk, JS Jaswal, J Cardiovasc Pharmacol 2010 56 130 140 10.1097/FJC.0b013e3181e74a14 20505524
50. Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. F Cao, RA Wagner, KD Wilson, X Xie, JD Fu, M Drukker, A Lee, RA Li, SS Gambhir, IL Weissman, RC Robbins, JC Wu, PLoS One 2008 3 3474 10.1371/journal.pone.0003474 18941512
51. Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. K Ojamaa, JD Klemperer, SS MacGilvray, I Klein, A Samarel, Endocrinology 1996 137 802 808 8603588 (Pubitemid 26074126)
52. Regulation of myosin heavy chain genes in the heart. E Morkin, Circulation 1993 87 1451 1460 10.1161/01.CIR.87.5.1451 8490999 (Pubitemid 23133087)
53. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. PW Ladenson, SI Sherman, KL Baughman, PE Ray, AM Feldman, Proc Natl Acad Sci U S A 1992 89 5251 5255 10.1073/pnas.89.12.5251 1376915
54. Thyroid hormone and the cardiovascular system. I Klein, K Ojamaa, N Engl J Med 2001 344 501 509 10.1056/NEJM200102153440707 11172193 (Pubitemid 32164903)
55. Biochemical basis of thyroid hormone action in the heart. WH Dillmann, Am J Med 1990 88 626 630 10.1016/0002-9343(90)90530-Q 2189306 (Pubitemid 20192278)
56. Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. E Kiss, G Jakab, EG Kranias, I Edes, Circ Res 1994 75 245 251 10.1161/01.RES.75.2.245 8033338
57. Thyroidal enhancement of rat myocardial Na, K-ATPase: preferential expression of alpha 2 activity and mRNA abundance. GG Gick, J Melikian, F Ismail-Beigi, J Membrane Biol 1990 115 273 282 10.1007/BF01868642 (Pubitemid 20171090)
58. Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid and chamber specific. K Ojamaa, A Sabet, A Kenessey, R Shenoy, I Klein, Endocrinology 1999 140 3170 3176 10385411 (Pubitemid 30650633)
59. Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. BD Hoit, SF Khoury, Y Shao, M Gabel, SB Liggett, RA Walsh, Circulation 1997 96 592 598 10.1161/01.CIR.96.2.592 9244231 (Pubitemid 27329439)
60. Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. K Ojamaa, I Klein, A Sabet, SF Steinberg, Metabolism 2000 49 275 279 10.1016/S0026-0495(00) 92262-5 10690958 (Pubitemid 30090897)
61. Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway. YK Lee, KM Ng, YC Chan, WH Lai, KW Au, CY Ho, LY Wong, CP Lau, HF Tse, CW Siu, Mol Endocrinol 2010 24 1728 1736 10.1210/me.2010-0032 20667986
62. Hormonal and metabolic changes in the perinatal period. F Mayor, JM Cuezva, Biol Neonate 1985 48 185 196 10.1159/000242171 2998491 (Pubitemid 16233145)
63. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. P Simpson, A McGrath, S Savion, Circ Res 1982 51 787 801 10.1161/01.RES.51.6.787 6216022 (Pubitemid 13217273)
64. Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. P Simpson, Circ Res 1985 56 884 894 10.1161/01.RES.56.6.884 2988814 (Pubitemid 15231512)
65. The L-type calcium channel current is increased by alpha-1 adrenoceptor activation in neonatal rat ventricular cells. QY Liu, E Karpinski, PK Pang, J Pharmacol Exp Ther 1994 271 935 943 7965815 (Pubitemid 24377784)
66. Alpha 1-adrenergic agonists selectively suppress voltage-dependent K + current in rat ventricular myocytes. M Apkon, JM Nerbonne, Proc Natl Acad Sci U S A 1988 85 8756 8760 10.1073/pnas.85.22.8756 2903506 (Pubitemid 19025034)
67. Developmental changes in beta2-adrenergic receptor signaling in ventricular myocytes: the role of Gi proteins and caveolae microdomains. VO Rybin, E Pak, S Alcott, SF Steinberg, Mol Pharmacol 2003 63 1338 1348 10.1124/mol.63.6.1338 12761344 (Pubitemid 36627229)
68. Transcriptome-guided functional analyses reveal novel biological properties and regulatory hierarchy of human embryonic stem cell-derived ventricular cardiomyocytes crucial for maturation. E Poon, B Yan, S Zhang, S Rushing, W Keung, L Ren, DK Lieu, L Geng, CW Kong, J Wang, HS Wong, KR Boheler, RA Li, PLoS One 2013 8 77784 10.1371/journal.pone.0077784 24204964
69. Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes. A Norstrom, K Akesson, T Hardarson, L Hamberger, P Bjorquist, P Sartipy, Exp Biol Med 2006 231 1753 1762 (Pubitemid 44865994)
70. Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells. XQ Xu, SY Soo, W Sun, R Zweigerdt, Stem Cells 2009 27 2163 2174 10.1002/stem.166 19658189
71. Molecular signature of cardiomyocyte clusters derived from human embryonic stem cells. J Synnergren, K Akesson, K Dahlenborg, H Vidarsson, C Ameen, D Steel, A Lindahl, B Olsson, P Sartipy, Stem Cells 2008 26 1831 1840 10.1634/stemcells.2007-1033 18436862
72. Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. A Beqqali, J Kloots, D Ward-van Oostwaard, C Mummery, R Passier, Stem Cells 2006 24 1956 1967 10.1634/stemcells.2006-0054 16675594 (Pubitemid 44474172)
73. MicroRNAs: target recognition and regulatory functions. DP Bartel, Cell 2009 136 215 233 10.1016/j.cell.2009.01.002 19167326
74. microRNAs in cardiac development and regeneration. ER Porrello, Clin Sci 2013 125 151 166 10.1042/CS20130011 23634935
75. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. JP Sluijter, A van Mil, P van Vliet, CH Metz, J Liu, PA Doevendans, MJ Goumans, Arterioscler Thromb Vasc Biol 2010 30 859 868 10.1161/ATVBAHA.109.197434 20081117
76. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. KD Wilson, S Hu, S Venkatasubrahmanyam, JD Fu, N Sun, OJ Abilez, JJ Baugh, F Jia, Z Ghosh, RA Li, AJ Butte, JC Wu, Circ Cardiovasc Genet 2010 3 426 435 10.1161/CIRCGENETICS.109. 934281 20733065
77. Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. JD Fu, SN Rushing, DK Lieu, CW Chan, CW Kong, L Geng, KD Wilson, N Chiamvimonvat, KR Boheler, JC Wu, G Keller, RJ Hajjar, RA Li, PLoS One 2011 6 27417 10.1371/journal.pone.0027417 22110643
78. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. KN Ivey, A Muth, J Arnold, FW King, RF Yeh, JE Fish, EC Hsiao, RJ Schwartz, BR Conklin, HS Bernstein, D Srivastava, Cell Stem Cell 2008 2 219 229 10.1016/j.stem.2008.01.016 18371447 (Pubitemid 351298595)
79. Regulation of histone methylation by demethylimination and demethylation. RJ Klose, Y Zhang, Nat Rev Mol Cell Biol 2007 8 307 318 10.1038/nrm2143 17342184 (Pubitemid 46474659)
80. Multivalent engagement of chromatin modifications by linked binding modules. AJ Ruthenburg, H Li, DJ Patel, CD Allis, Nat Rev Mol Cell Biol 2007 8 983 994 10.1038/nrm2298 18037899 (Pubitemid 350174643)
81. Regulation of chromatin by histone modifications. AJ Bannister, T Kouzarides, Cell Res 2011 21 381 395 10.1038/cr.2011.22 21321607
82. Polycomb silencing mechanisms and the management of genomic programmes. YB Schwartz, V Pirrotta, Nat Rev Genet 2007 8 9 22 17173055 (Pubitemid 46006046)
83. Dynamic link between histone H3 acetylation and an increase in the functional characteristics of human ESC/iPSC-derived cardiomyocytes. TG Otsuji, Y Kurose, H Suemori, M Tada, N Nakatsuji, PLoS One 2012 7 45010 10.1371/journal.pone.0045010 22984602
84. Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth. MZ Chow, L Geng, CW Kong, W Keung, JC Fung, KR Boheler, RA Li, Stem Cells Dev 2013 22 2678 2690 10.1089/scd.2013.0125 23656529
85. Cardiac chamber formation: development, genes, and evolution. AF Moorman, VM Christoffels, Physiol Rev 2003 83 1223 1267 14506305 (Pubitemid 37222272)
86. Nanotopographical control of stem cell differentiation. LE McNamara, RJ McMurray, MJ Biggs, F Kantawong, RO Oreffo, MJ Dalby, J Tissue Eng 2010 2010 120623 21350640
87. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. D Zhang, IY Shadrin, J Lam, HQ Xian, HR Snodgrass, N Bursac, Biomaterials 2013 34 5813 5820 10.1016/j.biomaterials.2013. 04.026 23642535
88. Anisotropic activation spread in heart cell monolayers assessed by high-resolution optical mapping. Role of tissue discontinuities. VG Fast, BJ Darrow, JE Saffitz, AG Kleber, Circ Res 1996 79 115 127 10.1161/01.RES.79.1.115 8925559
89. Influence of anisotropic conduction properties in the propagation of the cardiac action potential. M Valderrabano, Prog Biophys Mol Biol 2007 94 144 168 10.1016/j.pbiomolbio.2007.03.014 17482242 (Pubitemid 46782987)
90. Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. HT Au, I Cheng, MF Chowdhury, M Radisic, Biomaterials 2007 28 4277 4293 10.1016/j.biomaterials.2007.06.001 17604100 (Pubitemid 47212400)
91. Multiscale biomimetic topography for the alignment of neonatal and embryonic stem cell-derived heart cells. JI Luna, J Ciriza, ME Garcia-Ojeda, M Kong, A Herren, DK Lieu, RA Li, CC Fowlkes, M Khine, KE McCloskey, Tissue Eng C Methods 2011 17 579 588 10.1089/ten.tec.2010.0410
92. Shrink-film configurable multiscale wrinkles for functional alignment of human embryonic stem cells and their cardiac derivatives. A Chen, DK Lieu, L Freschauf, V Lew, H Sharma, J Wang, D Nguyen, I Karakikes, RJ Hajjar, A Gopinathan, E Botvinick, CC Fowlkes, RA Li, M Khine, Adv Mater 2011 23 5785 5791 10.1002/adma.201103463 22065428
93. Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias. J Wang, A Chen, DK Lieu, I Karakikes, G Chen, W Keung, CW Chan, RJ Hajjar, KD Costa, M Khine, RA Li, Biomaterials 2013 34 8878 8886 10.1016/j.biomaterials.2013.07.039 23942210
94. The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. C Rao, T Prodromakis, L Kolker, UA Chaudhry, T Trantidou, A Sridhar, C Weekes, P Camelliti, SE Harding, A Darzi, MH Yacoub, T Athanasiou, CM Terracciano, Biomaterials 2013 34 2399 2411 10.1016/j.biomaterials.2012.11.055 23261219
95. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. B Liau, N Christoforou, KW Leong, N Bursac, Biomaterials 2011 32 9180 9187 10.1016/j.biomaterials.2011.08.050 21906802
96. Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues. N Christoforou, B Liau, S Chakraborty, M Chellapan, N Bursac, KW Leong, PLoS One 2013 8 65963 10.1371/journal.pone.0065963 23785459
97. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. DK Lieu, JD Fu, N Chiamvimonvat, KC Tung, GP McNerney, T Huser, G Keller, CW Kong, RA Li, Circ Arrhythm Electrophysiol 2013 6 191 201 10.1161/CIRCEP.111.973420 23392582
98. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. P Rana, B Anson, S Engle, Y Will, Toxicol Sci 2012 130 117 131 10.1093/toxsci/kfs233 22843568
99. Mitochondrial membrane potential measurement of H9c2 cells grown in high-glucose and galactose-containing media does not provide additional predictivity towards mitochondrial assessment. P Rana, S Nadanaciva, Y Will, Toxicol In Vitro 2011 25 580 587 10.1016/j.tiv.2010.11.016 21126567